We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGC
326
PUT
Canopy Growth
CGC
$422M
$31K 0.01%
2,500
-16,810
-87% -$2.82M
IOVA icon
327
CALL
Iovance Biotherapeutics
IOVA
$2.94B
$31K 0.01%
40,300
-5,200
-11% -$159K
LFLYW
328
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$30K ﹤0.01%
55,321
-3,500
-6% -$2.37K
BMRN icon
329
CALL
BioMarin Pharmaceuticals
BMRN
$13.5B
$29K ﹤0.01%
+8,800
New +$890K
KYNB
330
CALL
Kyntra Bio
KYNB
$28.6M
$29K ﹤0.01%
+400
New +$430K
ARYBW
331
DELISTED
ARYA Sciences Acquisition Corp II Warrant
ARYBW
$29K ﹤0.01%
+16,323
New +$32.5K
BABA icon
332
PUT
Alibaba
BABA
$306B
$28K ﹤0.01%
22,900
– –
QQQ icon
333
PUT
Invesco QQQ Trust
QQQ
$478B
$28K ﹤0.01%
7,400
-50,000
-87% -$13.6M
NESRW
334
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$28K ﹤0.01%
40,214
-274,691
-87% -$229K
QDEL icon
335
CALL
QuidelOrtho
QDEL
$959M
$27K ﹤0.01%
+1,500
New +$335K
XBI icon
336
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$27K ﹤0.01%
22,000
-108,000
-83% -$12.1M
PRPB.WS
337
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$27K ﹤0.01%
+16,754
New +$28.3K
GRUB
338
PUT
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$27K ﹤0.01%
23,550
– –
XBI icon
339
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$26K ﹤0.01%
+22,000
New +$2.47M
ALACW
340
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$26K ﹤0.01%
125,757
-68,450
-35% -$11.3K
KYNB
341
PUT
Kyntra Bio
KYNB
$28.6M
$25K ﹤0.01%
+400
New +$430K
IFF icon
342
CALL
International Flavors & Fragrances
IFF
$21.7B
$25K ﹤0.01%
+7,200
New +$896K
SCVX.WS
343
DELISTED
SCVX Corp.
SCVX.WS
$25K ﹤0.01%
16,500
-19,008
-54% -$24.7K
GLEO.WS
344
DELISTED
Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
GLEO.WS
$25K ﹤0.01%
39,616
-51,304
-56% -$27.7K
IMMU
345
PUT
DELISTED
Immunomedics Inc
IMMU
$25K ﹤0.01%
+21,600
New +$1.09M
UKOMW
346
DELISTED
Ucommune International Ltd Warrant
UKOMW
$24K ﹤0.01%
80,000
– –
ASTSW
347
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$24K ﹤0.01%
19,917
-8,260
-29% -$8.22K
CORT icon
348
CALL
Corcept Therapeutics
CORT
$12.1B
$23K ﹤0.01%
19,000
-16,000
-46% -$255K
RIGL icon
349
PUT
Rigel Pharmaceuticals
RIGL
$785M
$23K ﹤0.01%
+3,750
New +$92.1K
VEDL
350
CALL
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$23K ﹤0.01%
+44,700
New +$293K
12 13
14
15 16

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.